IMMUNOGENICITY OF DNA VACCINE CONSTRUCTS ENCODING INFLUENZA VIRUS ARTIFICIAL ANTIGENS
- 作者: Starostina E.V.1, Kaplina O.N.1, Karpenko L.I.1, Dudko S.G.1, Bazhan S.I.1
-
隶属关系:
- State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor
- 期: 卷 22, 编号 2-2 (2019)
- 页面: 1024-1026
- 栏目: ORIGINAL ARTICLES
- URL: https://ogarev-online.ru/1028-7221/article/view/120250
- DOI: https://doi.org/10.31857/S102872210006484-7
- ID: 120250
如何引用文章
全文:
详细
作者简介
E. Starostina
State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor
编辑信件的主要联系方式.
Email: starostina_ev@vector.nsc.ru
researcher of Bioengineering Department,
Koltsovo, Novosibirsk region
俄罗斯联邦O. Kaplina
State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor
Email: fake@neicon.ru
researcher of Bioengineering Department,
Koltsovo, Novosibirsk region
俄罗斯联邦L. Karpenko
State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor
Email: fake@neicon.ru
PhD, Dr. Sci., head of Recombinant vaccines Laboratory of Bioengineering Department,
Koltsovo, Novosibirsk region
俄罗斯联邦S. Dudko
State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor
Email: fake@neicon.ru
researcher of Bioengineering Department,
Koltsovo, Novosibirsk region
俄罗斯联邦S. Bazhan
State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor
Email: fake@neicon.ru
PhD, Dr. Sci., head of Theoretical Department,
Koltsovo, Novosibirsk region
俄罗斯联邦参考
- Wacheck V., Egorov A., Groiss F., Pfeiff er A., Fuereder T., Hoefl mayer D., Kundi M., Popow-Kraupp T., Redlberger-Fritz M., Mueller C.A., Cinatl J., Michaelis M., Geiler J., Bergmann M., Romanova J., Roethl E., Morokutti A., Wolschek M., Ferko B., Seipelt J., DickGudenus R., Muster T. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis. 2010, 1; 201(3), 354–62.
- López-Macías C. Virus-like particle (VLP)-based vaccines for pandemic infl uenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccin Immunother. 2012, 8(3), 411–4.
- Draper S. J., Cottingham M. G., Gilbert S. C. Utilizing poxviral vectored vaccines for antibody inductionprogress and prospects. Vaccine 2013, 31, 4223–30. 4. Vemula S. V., Ahi Y. S., Swaim A. M., Katz J. M., Donis R., Sambhara S., Mittal S. K. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. PLoS One 2013, 8, 624–96.
补充文件
